Blue Jet Healthcare (BOM:544009) NonCurrent Deferred Liabilities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544009 Blue Jet Healthcare Ltd BOM:544009
65 GF Score
Price ₹587.45
GF Value ₹529.12
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Blue Jet Healthcare NonCurrent Deferred Liabilities?

Blue Jet Healthcare BOM:544009 +1.73% 65 NonCurrent Deferred Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:544009 with a GF Score™ of 65/100 and a GF Value™ of ₹529.12 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Blue Jet Healthcare's non-current deferred liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Blue Jet Healthcare NonCurrent Deferred Liabilities Related Terms

Blue Jet Healthcare NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Blue Jet Healthcare's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blue Jet Healthcare NonCurrent Deferred Liabilities Chart

Blue Jet Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Blue Jet Healthcare Quarterly Data
Mar21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:544009
65GF Score
Blue Jet Healthcare Ltd BOM:544009
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ₹0 Mil mean?
Blue Jet Healthcare (BOM:544009) has a NonCurrent Deferred Liabilities of ₹0 Mil as of Jun. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Blue Jet Healthcare and its competitors.
Is Blue Jet Healthcare's NonCurrent Deferred Liabilities too high?
Blue Jet Healthcare's current NonCurrent Deferred Liabilities is ₹0 Mil. Overall, Blue Jet Healthcare has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Blue Jet Healthcare's NonCurrent Deferred Liabilities of ₹0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Blue Jet Healthcare and its competitors. Blue Jet Healthcare's current NonCurrent Deferred Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹529.12, compared to a current price of ₹587.45 — trading 11% above its estimated fair value. The current NonCurrent Deferred Liabilities is ₹0 Mil. Blue Jet Healthcare's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current NonCurrent Deferred Liabilities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?

Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued. The current stock price of ₹587.45 is trading 11% above its estimated GF Value™ of ₹529.12. GuruFocus considers Blue Jet Healthcare to be Modestly Overvalued.

Key valuation signals for BOM:544009:

  • NonCurrent Deferred Liabilities: ₹0 Mil
  • GF Value™: ₹529.12 vs. price of ₹587.45 (11% above fair value)
  • GF Score™: 65/100 with 10 warning signs

No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blue Jet Healthcare Business Description

Other Exchanges BLUEJET:India
Address 701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, MH, IND, 400 705
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
65GF Score

Get the complete analysis for BOM:544009

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹587.45
Price
₹529.12
GF Value